US Seeks Therapies for Bundibugyo Ebola as DRC Outbreak Hits 670 Suspected Cases
Updated
Updated · Devdiscourse · May 22
US Seeks Therapies for Bundibugyo Ebola as DRC Outbreak Hits 670 Suspected Cases
12 articles · Updated · Devdiscourse · May 22
CDC official Satish Pillai said the United States is actively evaluating available products to identify therapies for the Bundibugyo Ebola strain spreading in the Democratic Republic of Congo.
160 suspected deaths among 670 suspected cases have pushed U.S. officials to assess which treatments are most appropriate and how to deliver them safely while measuring efficacy.
Pillai said the U.S. can test for Ebola through an integrated laboratory network supported by the Centers for Disease Control and Prevention.
The effort underscores the challenge of responding to a less common Ebola strain as the DRC outbreak drives an urgent search for workable therapeutics.
With existing vaccines useless, how can science outpace the third-largest Ebola outbreak in history?
How can health workers fight a deadly Ebola outbreak in the middle of an active conflict zone?